In the high-stakes realm of clinical-stage biotechnology, long-term shareholder value is fundamentally forged by pipeline assets that solve deep-seated clinical bottlenecks while...
Keep Reading →
September 23 - Hedge Funds, News
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory update as an earnings report.
Keep Reading →
September 3 - Hedge Funds, News
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Ocular Therapeuticx, Inc.
Keep Reading →
June 25 - News
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
Keep Reading →
June 24 - Hedge Funds, News
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
Keep Reading →
April 28 - Hedge Funds, News
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best low priced biotech stocks to invest in. Ocular Therapeutix Inc.
Keep Reading →
April 19 - News
In this article, we will look at the 8 Best Low Priced Biotech Stocks to Invest In.
Keep Reading →
April 18 - Hedge Funds, News
Ten stocks stood firmer on Thursday, as investors loaded portfolios in preparation for first quarter corporate earnings, with optimism supported by the broader market sentiment...
Keep Reading →
April 9 - Market Movers, News
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
Keep Reading →
March 31 - Hedge Funds, News
We came across a bullish thesis on Ocular Therapeutix, Inc. on r/Valueinvesting by Senior-Preference678. In this article, we will summarize the bulls’ thesis on OCUL.
Keep Reading →
February 28 - News, Stock Analysis
We came across a bullish thesis on Ocular Therapeutix, Inc. on TipRanks’ YouTube channel. In this article, we will summarize the bulls’ thesis on OCUL.
Keep Reading →
January 15 - News, Stock Analysis
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the low priced stocks to buy with high upside potential.
Keep Reading →
December 31 - News
On December 27, Michael Farr of Farr Miller & Washington appeared on CNBC's 'Closing Bell Overtime' to talk about his market predictions for 2026.
Keep Reading →
December 29 - Hedge Funds, News
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, H.C.
Keep Reading →
December 11 - News
In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts.
Keep Reading →
December 11 - Hedge Funds, News
We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is one of the best performers on Monday.
Keep Reading →
December 9 - News
We recently published 10 Firms Shining Bright in a Bleeding Market. Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best-performing stocks on Monday.
Keep Reading →
November 18 - News
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is one of the 15 stocks set to explode in 2026.
Keep Reading →
November 10 - News
In this article, we discuss the 15 stocks set to explode in 2026.
Keep Reading →
November 9 - Hedge Funds, News
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2025 Earnings Call Transcript November 4, 2025Ocular Therapeutix, Inc. beats earnings expectations.
Keep Reading →
November 5 - News, Transcripts
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best healthcare stocks with the highest upside. Ocular Therapeutix Inc. (NASDAQ:OCUL) received a rating update from H.C.
Keep Reading →
October 17 - News
In this article, we will look at the 10 Best Healthcare Stocks with the Highest Upside. On October 9, Dr.
Keep Reading →
October 17 - Hedge Funds, News
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best biotech stocks with high potential.
Keep Reading →
October 8 - News
In this article, we will look at the top 14 Biotech Stocks with High Potential.
Keep Reading →
October 7 - Hedge Funds, News
We recently published 11 Stocks Failing to Keep up With The Market. Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the top performers on Tuesday.
Keep Reading →
October 2 - News
In this article, we will look at the 11 Best Performing Long Term Stocks According to Analysts.
Keep Reading →
September 23 - Hedge Funds, News
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2025 Earnings Call Transcript August 5, 2025Ocular Therapeutix, Inc. misses on earnings expectations.
Keep Reading →
August 6 - News, Transcripts
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2024 Earnings Call Transcript March 3, 2025Ocular Therapeutix, Inc. misses on earnings expectations.
Keep Reading →
March 4 - News, Transcripts
Ocular Therapeutix, Inc.
Keep Reading →
November 15 - News, Transcripts
Ocular Therapeutix, Inc.
Keep Reading →
August 10 - News, Transcripts
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2023 Earnings Call Transcript November 7, 2023 Ocular Therapeutix, Inc. beats earnings expectations.
Keep Reading →
November 8 - News, Transcripts
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2023 Earnings Call Transcript August 7, 2023 Ocular Therapeutix, Inc. misses on earnings expectations.
Keep Reading →
August 8 - News, Transcripts
In this article, we will take a look at the 10 best rising penny stocks to buy.
Keep Reading →
July 13 - Hedge Funds, News
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2023 Earnings Call Transcript May 8, 2023 Ocular Therapeutix, Inc. misses on earnings expectations.
Keep Reading →
May 10 - News, Transcripts
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good afternoon, ladies and gentlemen.
Keep Reading →
March 8 - News, Transcripts
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Keep Reading →
December 23 - Hedge Funds, News
All eyes are on the tech sector after President Trump escalated the trade war with China by putting Chinese crown jewel Huawei on a blacklist.
Keep Reading →
May 20 - News
A whopping number of 13F filings filed with U.S.
Keep Reading →
December 15 - Hedge Funds, News
The markets have opened in the red despite applications for unemployment aid in the United States being at a 42-year low.
Keep Reading →
October 13 - News, Tech
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish.
Keep Reading →
June 6 - Market Movers, News
Founded in 2011, David Lamond's Lamond Capital Partners filed its first 13F form in 2012, when it held nearly $110 million in assets under management.
Keep Reading →
May 13 - Hedge Funds, News
Hedge Fund Resource Center 
